Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Ark Genomic Revolution Multi-Sector ETF (NY: ARKG)
33.70 USD  -0.32 (-0.94%)
Streaming Delayed Price  /  Updated: 2:24 PM EST, Feb 28, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
Ark Genomic Revolution Multi-Sector ETF
Sector
Exchange Traded NY
Net Assets 108.02M
Inception Date
Related Funds
Quote
Price 33.70
Volume 216,378
Last Trade Feb 28, 2:24pm
Change (%)
-0.32 (-0.94%)
Prev. Close 34.02
YTD %
+1.05%
Dividend Yield N/A
Performance
YTD
+0.35 (1.05%)
1 Month
-0.21 (-0.61%)
3 Month
-1.22 (-3.49%)
6 Month
+2.15 (6.81%)
1 Year
+2.52 (8.08%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
A Targeted Biotech ETF Is Brushing Off the Selling
Among the ares of the market that escaped the ongoing bloodshed on Wednesday, a biotechnology sector-related exchange traded fund stood out on better-than-expected quarterly earnings results and... Read More
from ETF Trends
Smaller Names Prove Potent For This Genomics ETF
There are areas of the burgeoning disruptive technologies space where investors may want to evaluate active management and genomics is one of those segments. The ARK Genomic Revolution Multi-Sector... Read More
from ETF Trends
Top News
More News
This Genomics ETF Has Coronavirus Vaccine Leverage
The race is on to find a cure for the deadly coronavirus and that competition could benefit some ETFs, including the ARK Genomic Revolution Multi-Sector Fund ( ARKG ) . Read More
from ETFdb
This Genomics ETF Has Some Coronavirus Vaccine Leverage
The race is on to find a cure for the deadly coronavirus and that competition could benefit some ETFs, including the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). ARKG includes companies that... Read More
from ETF Trends
Targeted ETFs Honing in on Ambitious Growth 2020 Ideas
As investors look to growth opportunities ahead, many are looking to ongoing technological breakthroughs and targeted ETF strategies to capture these growing segments and enhance a diversified... Read More
from ETFdb
Targeted ETFs to Hone in on Innovative Growth Ideas for 2020
As investors look to growth opportunities ahead, many are looking to ongoing technological breakthroughs and targeted ETF strategies to capture these growing segments and enhance a diversified... Read More
from ETF Trends
Big Ideas: Technological Breakthroughs Investors Shouldn’t Miss in 2020
ARK Invest has identified five innovation platforms that are evolving today and causing an increased amount of new technological breakthroughs. Companies that are leading and benefiting from these... Read More
from ETF Trends
Big Things Are Happening With This Genomics ETF
Investors looking for the intersection of healthcare and disruption need to look to genomics and DNA sequencing, two of the core focuses of the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG).... Read More
from ETF Trends
Teladoc Takes Flight, Helping This Disruptive Healthcare ETF
The J.P. Morgan healthcare conference is underway and the confab often viewed as the super bowl of healthcare meetings is already delivering some notable headlines for investors. The conference effect... Read More
from ETFdb
Teladoc Takes Flight, Boosting This Disruptive Healthcare ETF
The J.P. Morgan healthcare conference is underway and the confab often viewed as the super bowl of healthcare meetings is already delivering some notable headlines for investors. The conference effect... Read More
from ETF Trends
Illumina Stock May Illuminate This Healthcare ETF
Biotech firm Illumina, Inc. ( ILMN ) scrapped a merger with Pacific Biosciences, but there’s still a lot to like about Illumina and for investors that can’t handle the stock’s over $300 price tag, the... Read More
from ETFdb
Illumina Stock Could Illuminate This Healthcare ETF
Biotech firm Illumina, Inc. (NASDAQ: ILMN) scrapped a merger with Pacific Biosciences, but there’s still a lot to like about Illumina and for investors that can’t handle the stock’s over $300 price... Read More
from ETF Trends
Get Giddy For Genomics With This Biotech ETF
With healthcare and, more specifically, biotechnology stocks and ETFs on the mend, investors may want to consider getting tactical and focusing on one of the arena’s most potent growth avenues:... Read More
from ETFdb
Get Giddy For Genomics With This ETF
With healthcare and, more specifically, biotechnology stocks and ETFs on the mend, investors may want to consider getting tactical and focusing on one of the arena’s most potent growth avenues:... Read More
from ETF Trends
Forward-Looking Strategies With Actively Managed ETFs
Some money managers may loathe the idea of revealing their methodology in a fully transparent actively managed ETF, but others have fully embraced the investment vehicle to provide greater value to... Read More
from ETFdb
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.